• Picture of Prof. Irit Dinur

    Prof. Irit Dinur

    Probabilistically Checkable Proofs
    Hardness of Approximation

    Homepage
  • Picture of Prof. Rivka Dikstein

    Prof. Rivka Dikstein

    Transcription and translation control in health and disease
    Collaboration with:  Yuki Yamaguchi, Idit Shachar, Nahum Sonenberg, Yuri Svitkin, Franck Martin, Katsura Asano, Igor Ulitsky, Michael Walker, Neta Regev-Rudsky
    Mechanism of rapid transcriptional induction of inflammatory genes
    The transcription elongation factor Spt4/Spt5 as a drug target in neurodegenerative diseases
    Links between mammalian transcription and mRNA translation
    Developing pharmacological tools to address fundamental questions in mRNA translation and for therapeutic purposes
    Mechanism of start site selection in transcription and translation and its role in cancer and neurodegenerative diseases

    Homepage
  • Picture of Prof. Nava Dekel

    Prof. Nava Dekel

    Molecular characterization of the ovulatory cascade
    Mechanisms involved in successful implantation.
    Regulation of the meiotic cell cycle: use of rodent oocytes as a model system.
    Cell-to-cell communication: regulation of expression, posttranslational modification, degradation and function of the gap junction proteins, Cx43 and Cx37.

    Homepage
  • Picture of Prof. Hadassa Degani

    Prof. Hadassa Degani

    Advancements in pancreas MRI
    Collaboration with:  Dr. Talia Golan and her team, Sheba Medical Center
    Developing a diffusion tensor imaging (DTI) protocol to characterize the normal ductal system of the pancreas
    Developing DTI and complementary methods that characterize malignant transformation in the pancreas

    Homepage
  • Picture of Prof. Barak Dayan

    Prof. Barak Dayan

    Experimental Quantum Optics
    Cavity QED with single atoms coupled to chip-based micro-resonators
    Nonclassical photon-photon interactions

    Homepage
  • Picture of Prof. Nir Davidson

    Prof. Nir Davidson

    Ultracold atoms
    Collaboration with:  Ofer Firstenberg Ephi Sachmoon and Yaov Sagi
    Quantum simulators with neutral atoms in tweezer arrays
    Quantum degenerated atomic gases
    Collaboration with:  Roee Ozeri
    Quantum nonlinear dynamics and chaos
    Laser physics
    Collaboration with:  Asher Friesem, Hui Cao, Oren Raz
    Slow and stored light
    Collaboration with:  Ofer Firstenberg
    Atomic optics and interferometry
    Collaboration with:  Ofer Firstenberg

    Homepage
  • Picture of Dr. Rony Dahan

    Dr. Rony Dahan

    Antibody response in cancer
    Anti-tumor mechanisms of immune checkpoint antibodies
    Therapeutic window of antibody-based immunotherapies

    Homepage
  • Dr. Filipe Andre Natalio

    Material Farming: Where plant meet material sciences
    Collaboration with:  Dr. Michaela Eder and Prof. Peter Fratzl (Max Planck Institute of Colloids and Interfaces, Golm, Germany)
    We are interested in combining plant and material sciences to harness plants as biofactories to produce complex biological materials with tailored properties, with particular focus on cotton. Cotton is the global leading natural fiber involving 250 million around the world from farmer to retailer. Combining chemical synthesis of cotton fibers building blocks and a comprehensive understanding of the underlying biochemical and physiological mechanisms, we can produce cotton fibers with tailored properties such as increased hydrophobicity (think about your rain jacket). We coined this approach as Material Farming. This approach is an opportunity to implement sustainable alternative(s) to produce functional fibers overcoming the chemical fiber post-processing known to generate large amounts of chemical waste hazardous to the enviroment and humans. Finally, our approach will allow us to harness higher organisms' complexity, such as cotton plants, which can change how we currently think about the design of complex biological materials, plant sciences, and their physiology and biochemistry with a profound impact on the future of cotton-related industries.
    Scientific Archaeology - Artificial Inteligencemeets Archaeology
    Collaboration with:  Prof. Michael Chazan (University of Toronto) Dr. Liora Kolska Horowtiz (Hebrew University)
    We explore hidden signatures from the archaeological artifacts using artificial intelligence (AI) to infer human behavior. Our research explores cultural evolution and transmission in the Levant, the origin of domestication of cattle in the Fertile Crescent, and the relations between hominins and fire use. We combine the dozens of thousand unearthed and available archaeological remains (pottery, statues, stone tools, etc.) with AI to infer new relations between cultures - the known of the unknowns - while pinpointing the origin of revolutionary technologies their dispersion and implications to the cultural transmission continuum. We investigate the domestication of cattle, and their use for cultures was originated in the Fertile Crescent. What if older organic artifacts (plow) perished and the use of animals for plowing started earlier? We use AI combined with ancient cattle bones to find morphological changes induced by plowing and inform whether this behavior started earlier, implying a new conceptual understanding of a revolutionary technology that changed our way of living until today. Pyrotechnology is one of the most revolutionary advances in human evolution initiated about 2 million years ago. This technology allowed, for example, the cooking of food, changing our biochemistry (e.g., more energetic intake) and physiology (e.g., larger brain size). We develop new AI-based methodologies applied to flint stone tools (the most durable artifacts) that act as a thermometer to infer hominin relations with fire deep in time.
  • Picture of Prof. Irun R. Cohen

    Prof. Irun R. Cohen

    Development and clinical applications of an antigen microarray device and informatics analyses aimed at diagnosis, prognosis, monitoring and management of autoimmune and other inflammatory diseases – the ImmunArray Ltd iCHIP (Israel and USA); now in clinical use.
    Treatment of inflammatory bowel disease, arthritis and other autoimmune conditions using DNA plasmids encoding human HSP90 or HSP70 – Alma Bio Therapeutics (France).
    Treatment of ALS using a synthetic peptide that inhibits apoptosis and fosters cell growth – Immunity Pharma Ltd. (Israel); entering clinical trials.

    Homepage
  • Picture of Dr. Rei Chemke

    Dr. Rei Chemke

    Human impacts on the large-scale climate
    The large-scale flow in the atmosphere and ocean

    Homepage

Pages